Jett DA. 2016. The NIH Countermeasures Against Chemical Threats Program: overview and special challenges. Ann N Y Acad Sci. 1374 (1):5-9. PMID: 27398820.
Cywin CL, Tamiz AP. 2017. National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward. Neurotherapeutics. 14(4):1066-1069. PMID: 28405931.
Kehne JH, Klein BD, Raeissi S, Sharma S. 2017. The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP). Neurochem Res. 42(7):1894-1903. PMID: 28462454.
Schor NF, Tamiz AP, Koroshetz WJ; NINDS Ultra-Rare Gene-based Therapy (URGenT) Working Group, Broome AM. 2021. NINDS launches network to develop treatments for ultra-rare neurological diseases. Nat Biotechnol. PMID: 34737446.
Tamiz AP, Koroshetz WJ, Dhruv NT, Jett DA. 2022. A focus on the neural exposome. Neuron. PMID: 35349785.